Donatella Talotta

Novara, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

The integration of gene mutations and copy number variations refines the prognosis of mantle cell lymphoma: long-term results of the Fondazione Italiana Linfomi MCL0208 clinical trial.

The integration of gene mutations and copy number variations refines the prognosis of mantle cell lymphoma: long-term results of the Fondazione Italiana Linfomi MCL0208 clinical trial.

Journal: Leukemia

Published: March 04, 2025

Integration of [18F]FDG-PET radiomics with liquid biopsy improves outcome prediction in newly diagnosed diffuse large B-cell lymphoma.

Integration of [18F]FDG-PET radiomics with liquid biopsy improves outcome prediction in newly diagnosed diffuse large B-cell lymphoma.

Journal: Leukemia

Published: February 05, 2025

Immunoglobulin light chain mutational status refines IGHV prognostic value in identifying chronic lymphocytic leukemia patients with early treatment requirement.

Immunoglobulin light chain mutational status refines IGHV prognostic value in identifying chronic lymphocytic leukemia patients with early treatment requirement.

Journal: Leukemia

Published: August 13, 2024

Molecular measurable residual disease by immunoglobulin gene rearrangements on circulating tumor DNA predicts outcome in diffuse large B-cell lymphoma.

Molecular measurable residual disease by immunoglobulin gene rearrangements on circulating tumor DNA predicts outcome in diffuse large B-cell lymphoma.

Journal: Haematologica

Published: July 24, 2024

Molecular clustering on ctDNA improves the prognostic stratification of patients with DLBCL compared with ctDNA levels.

Molecular clustering on ctDNA improves the prognostic stratification of patients with DLBCL compared with ctDNA levels.

Journal: Blood advances

Published: July 19, 2024

XPO1 mutations identify early-stage CLL characterized by shorter time to first treatment and enhanced BCR signalling.

XPO1 mutations identify early-stage CLL characterized by shorter time to first treatment and enhanced BCR signalling.

Journal: British journal of haematology

Published: May 23, 2023

Liquid biopsy in hematological malignancies: current and future applications.

Liquid biopsy in hematological malignancies: current and future applications.

Journal: Frontiers in oncology

Published: February 12, 2023

Long-term benefit of IGHV mutated patients in a real-life multicenter cohort of FCR-treated chronic lymphocytic leukemia.

Long-term benefit of IGHV mutated patients in a real-life multicenter cohort of FCR-treated chronic lymphocytic leukemia.

Journal: Hematological oncology

Published: October 03, 2022

Clonally unrelated Richter syndrome are truly de novo diffuse large B-cell lymphomas with a mutational profile reminiscent of clonally related Richter syndrome.

Clonally unrelated Richter syndrome are truly de novo diffuse large B-cell lymphomas with a mutational profile reminiscent of clonally related Richter syndrome.

Journal: British journal of haematology

Published: May 21, 2022

Multiregional sequencing and circulating tumour DNA analysis provide complementary approaches for comprehensive disease profiling of small lymphocytic lymphoma.

Multiregional sequencing and circulating tumour DNA analysis provide complementary approaches for comprehensive disease profiling of small lymphocytic lymphoma.

Journal: British journal of haematology

Published: May 20, 2021

Showing 1-10 of 10

Last Updated: 09/26/2026